Wilson Sonsini, A&O Shearman Guide $688M Biotech Merger

Salt Lake City-based Recursion said Thursday it has inked a deal to purchase fellow drug design and development company Exscientia for approximately $688 million, under the guidance of Wilson Sonsini Goodrich & Rosati...

Already a subscriber? Click here to view full article